For patients with chronic lymphocytic leukemia (CLL) treated previously with venetoclax and Bruton’s tyrosine kinase ...

The FDA has approved updated drug labeling for Sandoz in the treatment of B-cell chronic lymphocytic leukemia.

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer ... the disease will progress and help your doctor choose which treatment options to use. The genetic testing to find such changes ...

Cyrus M. Khan, MD, discussed recent advancements in CLL treatment, particularly the shift to nonchemotherapy options and the ...

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

Jim Plotkin's year began just like any other back in 2018. The former touring golf professional and teaching professional at ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...

The FDA updated the fludarabine phosphate injection labeling under Project Renewal, clarifying the dosage for combination ...

Nurix Therapeutics (NRIX) announced that the European Medicines Agency, or EMA, has granted PRIME designation for NX-5948, a highly selective ...

GEO-CM04S1 Improved Immune Response vs mRNA VaccineATLANTA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...